Improving Prostate Cancer Understanding with AI
This study is looking at whether an artificial intelligence (AI) chatbot called Chat GPT can help patients better understand their prostate cancer diagnosis and pathology results. You might be able to join if you are over 18, have recently had a prostate biopsy at Cleveland Clinic main campus, haven't yet discussed your results, and speak English. The study wants to see how accurately participants understand their diagnosis and risk level after using Chat GPT. The study is currently recruiting about 50 participants.
- Study design
- This is an interventional study with an enrollment of 50 participants. It is not specified if it is randomized or blinded.
- What's involved
- You would spend up to 30 minutes interacting with Chat GPT on a Cleveland Clinic device during your appointment. You must also be willing to attend an in-person follow-up to review your pathology.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your understanding will be assessed approximately 70 minutes after interacting with Chat GPT.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Zeyad Schwen, MD · PRINCIPAL_INVESTIGATOR · Case Comprehensive Cancer Center, Cleveland Clinic Glickman Urologic Institute
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Accuracy as assessed by the rate of correctly identified and risk-stratified participants diagnosed with prostate cancerPost intervention(approximately 70 minutes)